MitoSciences was founded in 2004 by Dr. Roderick Capaldi and Dr. Michael Marusich with the mission of advancing mitochondrial research, and in particular, efforts to understand the role of the organelle in human diseases.
The Company has produced and continues to add to the world's largest collection of anti-mitochondrial monoclonal antibodies. These antibodies are being sold for life sciences research, developed into kits for drug discovery and drug toxicity studies, as well as being developed into tools for the diagnosis of the many mitochondrial-related diseases and for diagnosing mitochondrial toxicity from HAART.
The Company currently employs over 30 scientists, technicians, and administrative staff in its 7,000+ sq. ft. laboratory, cell culture, and office facilities adjacent to the University of Oregon.